Vir Biotechnology (VIR) Tax Rate (2018 - 2026)
Vir Biotechnology (VIR) posted Tax Rate of 0.14% for Q1 2026, down 142.57% sequentially from 0.32% in Q4 2025, and down 12.0% YoY from 0.15% in Q1 2025.
Powered by 
Analysis
Vir Biotechnology (VIR) Tax Rate (2018 - 2026) Analysis & Trends
Vir Biotechnology has reported Tax Rate for 9 years, with the latest figure at 0.14% in Q1 2026.
- Quarterly Tax Rate fell 12.0% year-over-year to 0.14% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.08% (down 33.0% YoY) and the FY2025 annual result came in at 0.05%, down 27.0% from the prior year.
- Tax Rate declined to 0.14% in Q1 2026 per VIR's latest filing, from 0.32% in the prior quarter.
- Over five years, Tax Rate peaked at 67.27% in Q2 2022 and troughed at 0.42% in Q1 2024.
- A 5-year average of 10.17% and a median of 1.08% in 2024 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2022 and 2023: Tax Rate jumped 6719 bps in 2022, then tumbled 6583 bps in 2023.
- Over 5 years, Tax Rate stood at 33.0% in 2022, then slumped by 88 bps to 3.96% in 2023, then slumped by 98 bps to 0.08% in 2024, then surged by 287 bps to 0.32% in 2025, then plunged by 143 bps to 0.14% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 0.14%, 0.32%, and 0.1% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -16.71% |
| 10 | Vir Biotechnology | 1.93 Bn | 1.93 Bn | 238.95 Mn | 0.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.22% |
| Mar 31, 2026 | -0.14% |
| Dec 31, 2025 | 0.32% |
| Sep 30, 2025 | -0.10% |
| Jun 30, 2025 | -0.15% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | 0.08% |
| Sep 30, 2024 | -0.08% |
| Jun 30, 2024 | 1.08% |
| Mar 31, 2024 | -0.42% |
| Dec 31, 2023 | 3.96% |
| Sep 30, 2023 | 1.93% |
| Jun 30, 2023 | 1.44% |
| Mar 31, 2023 | 1.56% |
| Dec 31, 2022 | 33.00% |
| Sep 30, 2022 | 19.48% |
| Jun 30, 2022 | 67.27% |
| Mar 31, 2022 | 43.74% |
| Dec 31, 2021 | 3.78% |
| Sep 30, 2021 | 0.30% |